REGORAFENIB

Basic Information

Item Value
DrugBank ID DB08896
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 18

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 adenocarcinoma of liver and intrahepatic biliary tract TxGNN Knowledge Graph
2 liver cancer TxGNN Knowledge Graph
3 squamous cell carcinoma of liver and intrahepatic biliary tract TxGNN Knowledge Graph
4 hepatocellular carcinoma TxGNN Knowledge Graph
5 pediatric hepatocellular carcinoma TxGNN Knowledge Graph
6 gastrointestinal stromal tumor TxGNN Knowledge Graph
7 metastasis from malignant tumor of colon TxGNN Knowledge Graph
8 fibrolamellar hepatocellular carcinoma TxGNN Knowledge Graph
9 undifferentiated carcinoma of liver and intrahepatic biliary tract TxGNN Knowledge Graph
10 adenocarcinoma of liver and intrahepatic biliary tract TxGNN Knowledge Graph
11 liver cancer TxGNN Knowledge Graph
12 squamous cell carcinoma of liver and intrahepatic biliary tract TxGNN Knowledge Graph
13 hepatocellular carcinoma TxGNN Knowledge Graph
14 pediatric hepatocellular carcinoma TxGNN Knowledge Graph
15 gastrointestinal stromal tumor TxGNN Knowledge Graph
16 metastasis from malignant tumor of colon TxGNN Knowledge Graph
17 fibrolamellar hepatocellular carcinoma TxGNN Knowledge Graph
18 undifferentiated carcinoma of liver and intrahepatic biliary tract TxGNN Knowledge Graph

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search